ArticleOncoTargets and therapy2019

Response to Afatinib in a Patient with Non-Small Cell Lung Cancer Harboring HER2 R896G Mutation: A Case Report.

Ling Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.